Publications by authors named "Michael D Howell"

Claim this Profile
C
Comparison of Tape-Stripping Platforms as Noninvasive Solutions for Skin Biomarker Discovery.
Erica N Montano, Ailyn Tapia, Michael D Howell, Jelena Ostojić

J Invest Dermatol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Generative artificial intelligence, patient safety and healthcare quality: a review.
Michael D Howell

BMJ Qual Saf· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Three Epochs of Artificial Intelligence in Health Care.
Michael D Howell, Greg S Corrado, Karen B DeSalvo

JAMA· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline Levels of Circulating Inflammatory Biomarkers Stratify Patients with Vitiligo Who Significantly Repigment after Treatment with Ruxolitinib Cream.
Michael D Howell, Fiona I Kuo, Beth Rumberger, Erika Boarder, Kang Sun

JID Innov· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SEB-induced IL-13 production in CLA memory T cells defines Th2 high and Th2 low responders in atopic dermatitis.
Lídia Sans-De San Nicolàs, Ignasi Figueras-Nart, Montserrat Bonfill-Ortí, Carmen De Jesús-Gil, Irene García-Jiménez, Michael D Howell

Allergy· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel proof-of-concept study assessing the lightening effects and safety of malassezin for treatment of facial hyperpigmentation.
Pearl E Grimes, Jag Bhawan, Michael D Howell, Seemal Desai, Edna Coryell

J Am Acad Dermatol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A biomarker signature to predict complete response to itacitinib and corticosteroids in acute graft-versus-host disease.
Michael Pratta, Sophie Paczesny, Gerard Socie, Natalie Barkey, Hao Liu, Michael D Howell

Br J Haematol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
Janus kinase 1 inhibitor INCB054707 for patients with moderate-to-severe hidradenitis suppurativa: results from two phase II studies.
Afsaneh Alavi, Iltefat Hamzavi, Kurt Brown, Leandro L Santos, Zhaoyin Zhu, Michael D Howell

Br J Dermatol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient and Clinician Perceptions of Factors Relevant to Ideal Specialty Consultations.
Stephanie D Roche, Anna C Johansson, Jaclyn Giannakoulis, Michael N Cocchi, Michael D Howell

JAMA Netw Open· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to Marchetti et al.
Darrell S Rigel, John W Whitaker, Maral K Skelsey, Gary Peck, Michael D Howell

J Invest Dermatol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Privacy-first health research with federated learning.
Adam Sadilek, Luyang Liu, Dung Nguyen, Methun Kamruzzaman, Stylianos Serghiou, Michael D Howell

NPJ Digit Med· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modernizing Public Health Data Systems: Lessons From the Health Information Technology for Economic and Clinical Health (HITECH) Act.
Kushal T Kadakia, Michael D Howell, Karen B DeSalvo

JAMA· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic Atypia of Lesions Clinically Suspicious for Melanoma Is Confined to Lesional Tissue Within Narrow Margins.
Ronald Moy, Daniel M Siegel, Zuxu Yao, Jim Rock, Michael D Howell

J Drugs Dermatol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modeling Skin Inflammation Using Human In Vitro Models.
Erika Boarder, Beth Rumberger, Michael D Howell

Curr Protoc· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interplay between Humoral and CLA T Cell Response against in Psoriasis.
Carmen de Jesús-Gil, Lídia Sans-de San Nicolàs, Ester Ruiz-Romeu, Marta Ferran, Laura Soria-Martínez, Michael D Howell

Int J Mol Sci· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting the Janus Kinase Family in Autoimmune Skin Diseases.
Michael D Howell, Fiona I Kuo, Paul A Smith

Front Immunol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcriptomic analysis of hidradenitis suppurativa skin suggests roles for multiple inflammatory pathways in disease pathogenesis.
Beth E Rumberger, Erika L Boarder, Sherry L Owens, Michael D Howell

Inflamm Res· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fighting pandemics with digital epidemiology.
Sasu Tarkoma, Suliman Alghnam, Michael D Howell

EClinicalMedicine· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting Inpatient Medication Orders From Electronic Health Record Data.
Kathryn Rough, Andrew M Dai, Kun Zhang, Yuan Xue, Laura M Vardoulakis, Michael D Howell

Clin Pharmacol Ther· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Ruxolitinib cream for treatment of vitiligo: a randomised, controlled, phase 2 trial.
David Rosmarin, Amit G Pandya, Mark Lebwohl, Pearl Grimes, Iltefat Hamzavi, Michael D Howell

Lancet· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Ruxolitinib for the treatment of steroid-refractory acute GVHD (REACH1): a multicenter, open-label phase 2 trial.
Madan Jagasia, Miguel-Angel Perales, Mark A Schroeder, Haris Ali, Nirav N Shah, Michael D Howell

Blood· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bundled Consent in US Intensive Care Units.
Maria L Espinosa, Aaron M Tannenbaum, Megha Kilaru, Jennifer Stevens, Mark Siegler, Michael D Howell

Am J Crit Care· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of atopic dermatitis with ruxolitinib cream (JAK1/JAK2 inhibitor) or triamcinolone cream.
Brian S Kim, Michael D Howell, Kang Sun, Kim Papp, Adnan Nasir

J Allergy Clin Immunol· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atopic Dermatitis Endotypes Based on Allergen Sensitization, Reactivity to Staphylococcus aureus Antigens, and Underlying Systemic Inflammation.
Alexandra Leonard, Jingya Wang, Li Yu, Hao Liu, Yeriel Estrada, Michael D Howell

J Allergy Clin Immunol Pract· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Customization scenarios for de-identification of clinical notes.
Tzvika Hartman, Michael D Howell, Jeff Dean, Shlomo Hoory, Ronit Slyper

BMC Med Inform Decis Mak· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis